The miR-34 isoforms have been clinically characterized as tumor suppressors in multiple cancer types, often independent of p53 mutation, as in neuroblastoma, where mir-34a is commonly deleted26, 27, or in other cancers characterized by epigenetic silencing of miR-3428, 29. This evidence concerns the gene TP53 and cancer.